Efficacy and Safety of CAM2029 in Patients With Controlled or Inadequately Controlled Acromegaly on Standard-of-Care Treatment: Interim Data for the New to CAM2029 Patient Subgroup in a Phase 3 Study (ACROINNOVA 2)

The requested reference [1371907c3dad7213f92f76df6e36688b0daa3060] no longer exists in our database. It has been replaced by the current reference: [0d117b07f45d0c28677eb2414cbfd1c261eb5d96]

Authors
Category Primary study
JournalJournal of the Endocrine Society
Year 2024
This article has no abstract
Epistemonikos ID: f6287612b9707c736a1f0b0e6271ec3afd8f0faa
First added on: Feb 19, 2025